BENDROFLUAZIDE Safety Questions, BENDROFLUAZIDE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about BENDROFLUAZIDE. Our extensive database of BENDROFLUAZIDE adverse events and BENDROFLUAZIDE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about BENDROFLUAZIDE
BENDROFLUAZIDE Safety Reports
Total BENDROFLUAZIDE reports: 3.BENDROFLUAZIDE FDA safety alerts: No.
Reported hospitalizations: 2.
Take BENDROFLUAZIDE Side Effects Survey or Share Your BENDROFLUAZIDE Story. Read More Here.
Health Professional from UNITED KINGDOM reported BENDROFLUAZIDE problem on May 16, 2007. Male patient, 52 years of age, weighting 282.2 lb, was diagnosed with ill-defined disorder, hypertension, obesity and was treated with BENDROFLUAZIDE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased. BENDROFLUAZIDE dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE, XENICAL. Patient recovered.
BENDROFLUAZIDE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 23, 2003. Female patient, weighting 141.1 lb, was diagnosed with ill-defined disorder, cardiac failure congestive and was treated with BENDROFLUAZIDE. After drug was administered, patient experienced the following problems/side effects: cataract operation, dehydration, diarrhoea, fall, sympathectomy. BENDROFLUAZIDE dosage: unknown. During the same period patient was treated with PERINDOPRIL ERBUMINE, GLICLAZIDE, FOLIC ACID, ACETYLSALICYLIC ACID SRT, SIMVASTATIN, PILOCARPINE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported BENDROFLUAZIDE problem on Nov 28, 2006. Female patient, weighting 198.4 lb, was diagnosed with colorectal cancer metastatic and was treated with BENDROFLUAZIDE. After drug was administered, patient experienced the following problems/side effects: aphagia, areflexia, balance disorder, cerebrovascular accident, hemiparesis. BENDROFLUAZIDE dosage: unknown. During the same period patient was treated with AMLODIPINE, ORAMORPH, FENTANYL, CETUXIMAB, FLUOROURACIL, LEUCOVORIN CALCIUM, OXALIPLATIN. Patient was hospitalized. Patient recovered.